The Effect of a Nationwide Infection Control Program Expansion on Hospital-Onset Gram-Negative Rod Bacteremia in 130 Veterans Health Administration Medical Centers: An Interrupted Time-Series Analysis

Clinical Infectious Diseases

Volumn 63, Issue 5, 2016, Pages 642-650

  Goto, Michihiko ^a   O'Shea, Amy M J ^a   Livorsi, Daniel J ^a   McDanel, Jennifer S ^a   Jones, Makoto M ^b,c   Richardson, Kelly K ^a   Beck, Brice F ^a   Alexander, Bruce ^a   Evans, Martin E ^d,e,f   Roselle, Gary A ^g,h,i   Kralovic, Stephen M ^g,h,i   Perencevich, Eli N ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Salt Lake City VA Health Care System   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Veterans Health Administration (VHA) MDRO Program Office   (United States)

^e LEXINGTON VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g VHA National Infectious Diseases Service   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

gram negative bacteremia; hospital onset bacteremia; infection control; interrupted time series analysis

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; PSEUDOMONAS AERUGINOSA; QUASI EXPERIMENTAL STUDY; RETROSPECTIVE STUDY; BACTEREMIA; CROSS INFECTION; GOVERNMENT; GRAM NEGATIVE INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROCEDURES; STAPHYLOCOCCUS INFECTION; STATISTICS AND NUMERICAL DATA; UNITED STATES; VETERAN;

AGED; BACTEREMIA; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 84995520617     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw423     Document Type: Article

References (39)

1. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34:1-14.
2. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41:848-54.
3. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010; 14(suppl 4):S3-5.
4. Septimus E, Weinstein RA, Perl TM, Goldmann DA, Yokoe DS. Approaches for preventing healthcare-associated infections: go long or go wide? Infect Control Hosp Epidemiol 2014; 35:797-801.
5. Perencevich EN. Deconstructing the Veterans Affairs MRSA prevention bundle. Clin Infect Dis 2012; 54:1621-3.
6. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364:1419-30.
7. Evans ME, Kralovic SM, Simbartl LA, et al. Veterans Affairs methicillin-resistant Staphylococcus aureus prevention initiative associated with a sustained reduction in transmissions and health care-associated infections. Am J Infect Control 2013; 41:1093-5.
8. Evans ME, Simbartl LA, Kralovic SM, Jain R, Roselle GA. Clostridium difficile infections in Veterans Health Administration acute care facilities. Infect Control Hosp Epidemiol 2014; 35:1037-42.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
10. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137:791-7.
11. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-81.
12. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Health care associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 2006; 34:2588-95.
13. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006; 10:320-5.
14. Luzzaro F, Vigano EF, Fossati D, et al. Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis 2002; 21:849-55.
15. Al-Hasan MN, Eckel-Passow JE, Baddour LM. Impact of healthcare-associated acquisition on community-onset gram-negative bloodstream infection: a population-based study: healthcare-associated gram-negative BSI. Eur J Clin Microbiol Infect Dis 2012; 31:1163-71.
16. Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 2007; 167:834-9.
17. Sogaard M, Lyytikainen O, Laupland KB, Schonheyder HC. Monitoring the epidemiology of bloodstream infections: aims, methods and importance. Expert Rev Anti Infect Ther 2013; 11:1281-90.
18. Rodriguez-Creixems M, Alcala L, Munoz P, Cercenado E, Vicente T, Bouza E. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 2008; 87:234-49.
19. Veterans Health Administration. About VHA. Available at: http://www.va.gov/health/aboutVHA.asp. Accessed 11 February 2016.
20. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston, Massachusetts: Wadsworth Cengage Learning, 2002.
21. Marsh DR, Schroeder DG, Dearden KA, Sternin J, Sternin M. The power of positive deviance. BMJ 2004; 329:1177-9.
22. Positive Deviance Initiative. Available at: http://www.positivedeviance.org/. Accessed 22 April 2016.
23. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27:299-309.
24. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health 1981; 71:38-46.
25. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care 1998; 36:321-32.
26. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol 2009; 62:143-8.
27. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospitalacquired pneumonia. Infect Control Hosp Epidemiol 2007; 28:825-31.
28. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-8.
29. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheterrelated bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-32.
30. Ortega M, Marco F, Soriano A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63:568-74.
31. Jones M, Nielson C, Gupta K, Khader K, Evans M. Collateral benefit of screening patients for methicillin-resistant Staphylococcus aureus at hospital admission: isolation of patients with multidrug-resistant gram-negative bacteria. Am J Infect Control 2015; 43:31-4.
32. Snyder GM, O'Fallon E, D'Agata EM. Co-colonization with multiple different species of multidrug-resistant gram-negative bacteria. Am J Infect Control 2011; 39:506-10.
33. Jans B, Schoevaerdts D, Huang TD, et al. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One 2013; 8: e64908.
34. Rhee C, Murphy MV, Li L, et al. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis 2015; 60:88-95.
35. Iwashyna TJ, Odden A, Rohde J, et al. Identifying patients with severe sepsis using administrative claims: patient-level validation of the Angus Implementation of the International Consensus Conference definition of severe sepsis. Med Care 2014; 52:e39-43.
36. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311:1308-16.
37. Schweizer ML, Eber MR, Laxminarayan R, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011; 32:148-54.
38. Jones BE, Jones MM, Huttner B, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010. Clin Infect Dis 2015; 61:1403-10.
39. Render ML, Hasselbeck R, Freyberg RW, et al. Reduction of central line infections in Veterans Administration intensive care units: an observational cohort using a central infrastructure to support learning and improvement. BMJ Qual Saf 2011; 20:725-32.